which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Possible role of glial cells in the onset and progression of Lyme neuroborreliosis
暂无分享,去创建一个
L. Morici | P. Didier | M. Philipp | P. Mottram | Dale S. Martin | G. Ramesh | M. B. Jacobs | J. Borda | E. Ribka | A. Gill | D. Martin | Amy F. Gill | Mary B. Jacobs
[1] A. Lackner,et al. Interaction of the Lyme disease spirochete Borrelia burgdorferi with brain parenchyma elicits inflammatory mediators from glial cells as well as glial and neuronal apoptosis. , 2008, The American journal of pathology.
[2] A. Mauborgne,et al. JAK/STAT3 pathway is activated in spinal cord microglia after peripheral nerve injury and contributes to neuropathic pain development in rat , 2008, Journal of neurochemistry.
[3] A. Hasegawa,et al. Toll-Like Receptors: Insights into Their Possible Role in the Pathogenesis of Lyme Neuroborreliosis , 2008, Infection and Immunity.
[4] J. Halperin. Nervous system Lyme disease. , 2008, Infectious disease clinics of North America.
[5] H. Pfister,et al. The Pathogenesis of Lyme Neuroborreliosis: From Infection to Inflammation , 2008, Molecular medicine.
[6] R. Keep,et al. Effects of the Chemokine CCL2 on Blood–Brain Barrier Permeability during Ischemia–Reperfusion Injury , 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[7] J. Weinstein,et al. Effects of interleukin-1 beta, interleukin-6, and tumor necrosis factor on sensitivity of dorsal root ganglion and peripheral receptive fields in rats , 2006, European Spine Journal.
[8] H. Pfister,et al. The chemokine CXCL13 (BLC): A putative diagnostic marker for neuroborreliosis , 2005, Neurology.
[9] P. Fitzgerald-Bocarsly,et al. The nervous system as ectopic germinal center: CXCL13 and IgG in lyme neuroborreliosis , 2005, Annals of neurology.
[10] M. Hanani. Satellite glial cells in sensory ganglia: from form to function , 2005, Brain Research Reviews.
[11] K. Krause,et al. Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases , 2005, Brain Research Reviews.
[12] A. Lackner,et al. Visualizing Cytokine-Secreting Cells In Situ in the Rhesus Macaque Model of Chronic Gut Inflammation , 2005, Clinical Diagnostic Laboratory Immunology.
[13] E. Tuomanen,et al. Dual phases of apoptosis in pneumococcal meningitis. , 2004, The Journal of infectious diseases.
[14] R. Świerzbińska,et al. [Role of interleukin-18, interleukin-1beta and its soluble receptor (sIL-1RII) in early and late Lyme borreliosis]. , 2004, Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego.
[15] J. Zajkowska,et al. [Evaluation of proinflammatory cytokine (TNF-alpha, IL-1beta, IL-6, IFN-gamma) concentrations in serum and cerebrospinal fluid of patients with neuroborreliosis]. , 2004, Neurologia i neurochirurgia polska.
[16] S. Barthold,et al. Spinal cord involvement in the nonhuman primate model of Lyme disease , 2004, Laboratory Investigation.
[17] B. Sander,et al. Phenotypes indicating cytolytic properties of Borrelia-specific interferon-γ secreting cells in chronic Lyme neuroborreliosis , 2003, Journal of Neuroimmunology.
[18] C. Godson,et al. Phagocytosis of apoptotic cells and the resolution of inflammation. , 2003, Biochimica et biophysica acta.
[19] V. Dennis,et al. Pathogenesis of Lyme neuroborreliosis: Borrelia burgdorferi lipoproteins induce both proliferation and apoptosis in rhesus monkey astrocytes , 2003, European journal of immunology.
[20] W. Kuziel,et al. Chemokine Expression by Glial Cells Directs Leukocytes to Sites of Axonal Injury in the CNS , 2003, The Journal of Neuroscience.
[21] S. Cepok,et al. The immune response at onset and during recovery from Borrelia burgdorferi meningoradiculitis. , 2003, Archives of neurology.
[22] C. Brosnan,et al. Cytokines: Powerful Regulators of Glial Cell Activation , 2003, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[23] R. Ransohoff,et al. The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE). , 2003, Seminars in immunology.
[24] H. Pfister,et al. Pathophysiology of bacterial meningitis: mechanism(s) of neuronal injury. , 2002, The Journal of infectious diseases.
[25] O. Beran,et al. Lymphocyte subset numbers in cerebrospinal fluid: comparison of tick‐borne encephalitis and neuroborreliosis , 2002, Acta neurologica Scandinavica.
[26] J. Ernerudh,et al. Cytokines in Lyme borreliosis: lack of early tumour necrosis factor‐α and transforming growth factor‐β1 responses are associated with chronic neuroborreliosis , 2002 .
[27] R. Klingebiel,et al. Large cerebral vessel occlusive disease in Lyme neuroborreliosis. , 2002, Neuropediatrics.
[28] W. Brück,et al. Neuronal injury in bacterial meningitis: mechanisms and implications for therapy , 2002, Trends in Neurosciences.
[29] P. Grammas,et al. Inflammatory factors are elevated in brain microvessels in Alzheimer’s disease , 2001, Neurobiology of Aging.
[30] B. Rollins,et al. Absence of Monocyte Chemoattractant Protein 1 in Mice Leads to Decreased Local Macrophage Recruitment and Antigen-Specific T Helper Cell Type 1 Immune Response in Experimental Autoimmune Encephalomyelitis , 2001, The Journal of experimental medicine.
[31] S. Majumder,et al. Chemokines and chemokine receptors in inflammation of the nervous system: manifold roles and exquisite regulation , 2000, Immunological reviews.
[32] D. Cadavid,et al. Localization of Borrelia Burgdorferi in the Nervous System and Other Organs in a Nonhuman Primate Model of Lyme Disease , 2000, Laboratory Investigation.
[33] F. Liang,et al. Analysis of Antibody Response to Invariable Regions of VlsE, the Variable Surface Antigen of Borrelia burgdorferi , 1999, Infection and Immunity.
[34] P. Richardson,et al. Nature of the Retrograde Signal from Injured Nerves that Induces Interleukin-6 mRNA in Neurons , 1999, The Journal of Neuroscience.
[35] C. Marra,et al. Mechanisms of clearance of Treponema pallidum from the CSF in a nonhuman primate model , 1998, Neurology.
[36] G. Habicht,et al. Pathogenesis of Lyme neuroborreliosis in the rhesus monkey: the early disseminated and chronic phases of disease in the peripheral nervous system. , 1998, The Journal of infectious diseases.
[37] K. Spanaus,et al. Chemokines and chemotaxis of leukocytes in infectious meningitis , 1998, Journal of Neuroimmunology.
[38] U. Otten,et al. Interleukin-6 (IL-6)—A molecule with both beneficial and destructive potentials , 1997, Progress in Neurobiology.
[39] C. Hughes,et al. Interleukin-6 is expressed at high levels in the CNS in Lyme neuroborreliosis , 1997, Neurology.
[40] J. England,et al. Mononeuropathy multiplex in rhesus monkeys with chronic lyme disease , 1997, Annals of neurology.
[41] H. Kalimo,et al. Inflammatory brain changes in Lyme borreliosis. A report on three patients and review of literature. , 1996, Brain : a journal of neurology.
[42] R. Ransohoff,et al. Chemokines in immune-mediated inflammation of the central nervous system. , 1996, Cytokine & growth factor reviews.
[43] H. Link,et al. Lyme Neuroborreliosis: Evidence for Persistent Up‐Regulation of Borrelia Burgdorferi‐Reactive Cells Secreting Interferon‐γ , 1995, Scandinavian journal of immunology.
[44] G. Randolph,et al. A soluble gradient of endogenous monocyte chemoattractant protein-1 promotes the transendothelial migration of monocytes in vitro. , 1995, Journal of immunology.
[45] J. Grondin,et al. Induction of interleukin-6 in axotomized sensory neurons , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[46] D. Ferriero,et al. Brain Injury in Experimental Neonatal Meningitis Due to Group B Streptococci , 1995, Journal of neuropathology and experimental neurology.
[47] E. Major,et al. Inoculation of nonhuman primates with the N40 strain of Borrelia burgdorferi leads to a model of lyme neuroborreliosis faithful to the human disease , 1995, Neurology.
[48] T. Springer,et al. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[49] Y. Gu,et al. Early and early disseminated phases of Lyme disease in the rhesus monkey: a model for infection in humans , 1993, Infection and immunity.
[50] E. Benveniste. Inflammatory cytokines within the central nervous system: sources, function, and mechanism of action. , 1992, The American journal of physiology.
[51] R. C. Rogers,et al. Borrelia burgdorferi and other related spirochetes bind to galactocerebroside , 1992, Neurology.
[52] R. Fishman. Cerebrospinal Fluid in Diseases of the Nervous System , 1992 .
[53] D. Graves,et al. Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes. , 1992, Journal of immunology.
[54] A. Huber,et al. Regulation of transendothelial neutrophil migration by endogenous interleukin-8. , 1991, Science.
[55] J. Benach,et al. Cytokines and the pathogenesis of neuroborreliosis: Borrelia burgdorferi induces glioma cells to secrete interleukin-6. , 1991, The Journal of infectious diseases.
[56] J. Dichgans,et al. Cerebrospinal fluid interleukins, immunoglobulins, and fibronectin in neuroborreliosis. , 1991, Archives of neurology.
[57] O. Ramilo,et al. Tumor necrosis factor alpha/cachectin and interleukin 1 beta initiate meningeal inflammation , 1990, The Journal of experimental medicine.
[58] J. Benach,et al. Adherence of the Lyme disease spirochete to glial cells and cells of glial origin. , 1989, The Journal of infectious diseases.
[59] R. Griggs. Cerebrospinal Fluid in Diseases of the Nervous System , 1981, Neurology.
[60] J. Zajkowska,et al. Concentration of interferon-inducible T cell chemoattractant and monocyte chemotactic protein-1 in serum and cerebrospinal fluid of patients with Lyme borreliosis. , 2005, Roczniki Akademii Medycznej w Bialymstoku.
[61] K. Jessen,et al. Glial cells. , 2004, The international journal of biochemistry & cell biology.
[62] T. Kielian. Microglia and chemokines in infectious diseases of the nervous system: views and reviews. , 2004, Frontiers in bioscience : a journal and virtual library.
[63] J. Ernerudh,et al. Cytokines in Lyme borreliosis: lack of early tumour necrosis factor-alpha and transforming growth factor-beta1 responses are associated with chronic neuroborreliosis. , 2002, Immunology.
[64] K. Gustaw,et al. Neurological and psychological symptoms after the severe acute neuroborreliosis. , 2001, Annals of Agricultural and Environmental Medicine.
[65] B. Moser,et al. Cytokines and chemokines in meningeal inflammation: biology and clinical implications. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[66] G. Kreutzberg,et al. Molecular signals for glial activation: pro- and anti-inflammatory cytokines in the injured brain. , 1999, Acta neurochirurgica. Supplement.
[67] J. Tekstra,et al. Expression of MCP-1 by reactive astrocytes in demyelinating multiple sclerosis lesions. , 1999, The American journal of pathology.
[68] G. Germanà,et al. Immunohistochemical localization of S100 proteins in dorsal root, sympathetic and enteric ganglia of several mammalian species, including man. , 1998, Journal of the peripheral nervous system : JPNS.
[69] R. Zinkernagel,et al. Tumor necrosis factor alpha in cerebrospinal fluid during bacterial, but not viral, meningitis. Evaluation in murine model infections and in patients , 1988, The Journal of experimental medicine.